I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| ciliated cell | 7 studies | 24% ± 8% | |
| glutamatergic neuron | 4 studies | 29% ± 11% | |
| interneuron | 3 studies | 23% ± 7% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| ciliated cell | 7 studies | 24% ± 8% | |
| glutamatergic neuron | 4 studies | 29% ± 11% | |
| interneuron | 3 studies | 23% ± 7% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 5 studies | 20% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| thymus | 100% | 635.47 | 653 / 653 | 100% | 6.31 | 605 / 605 |
| uterus | 100% | 624.61 | 170 / 170 | 100% | 5.71 | 458 / 459 |
| prostate | 100% | 694.69 | 244 / 245 | 100% | 5.24 | 502 / 502 |
| esophagus | 100% | 537.14 | 1439 / 1445 | 100% | 4.73 | 183 / 183 |
| breast | 100% | 579.61 | 459 / 459 | 99% | 4.99 | 1112 / 1118 |
| ovary | 99% | 518.66 | 179 / 180 | 100% | 4.50 | 430 / 430 |
| intestine | 100% | 621.89 | 965 / 966 | 99% | 3.76 | 524 / 527 |
| lung | 99% | 577.27 | 573 / 578 | 99% | 5.41 | 1149 / 1155 |
| pancreas | 99% | 302.88 | 326 / 328 | 99% | 4.77 | 176 / 178 |
| stomach | 99% | 374.52 | 355 / 359 | 99% | 3.36 | 283 / 286 |
| skin | 100% | 586.02 | 1808 / 1809 | 97% | 8.23 | 458 / 472 |
| kidney | 100% | 673.19 | 89 / 89 | 96% | 4.11 | 863 / 901 |
| bladder | 95% | 361.52 | 20 / 21 | 100% | 6.49 | 502 / 504 |
| adrenal gland | 99% | 524.51 | 255 / 258 | 90% | 2.65 | 207 / 230 |
| brain | 100% | 1051.29 | 2633 / 2642 | 71% | 2.59 | 499 / 705 |
| liver | 43% | 75.58 | 97 / 226 | 58% | 1.27 | 234 / 406 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 5.46 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 9.90 | 1 / 1 |
| adipose | 100% | 500.88 | 1202 / 1204 | 0% | 0 | 0 / 0 |
| spleen | 100% | 252.85 | 240 / 241 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 99% | 4.69 | 79 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 93% | 2.94 | 27 / 29 |
| heart | 92% | 282.42 | 793 / 861 | 0% | 0 | 0 / 0 |
| blood vessel | 84% | 239.19 | 1125 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 40% | 69.92 | 321 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 28% | 57.37 | 257 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_1902110 | Biological process | positive regulation of mitochondrial membrane permeability involved in apoptotic process |
| GO_0043065 | Biological process | positive regulation of apoptotic process |
| GO_0005739 | Cellular component | mitochondrion |
| GO_0005634 | Cellular component | nucleus |
| GO_0003674 | Molecular function | molecular_function |
| Gene name | STPG1 |
| Protein name | O(6)-methylguanine-induced apoptosis 2 (MAPO2) (Sperm-tail PG-rich repeat-containing protein 1) Sperm tail PG-rich repeat containing 1 |
| Synonyms | C1orf201 |
| Description | FUNCTION: May positively contribute to the induction of apoptosis triggered by O(6)-methylguanine. . |
| Accessions | ENST00000003583.12 [Q5TH74-3] ENST00000435187.1 Q5TH77 H0Y4J3 ENST00000374409.5 [Q5TH74-1] Q5TH74 ENST00000337248.9 [Q5TH74-1] ENST00000438866.1 |
